Page 87 - Molecular features of low-grade developmental brain tumours

DISTINCT DNA METHYLATION PATTERNS IN SEGA IN TSC
39. Fabregat, A. et al. The Reactome Pathway Knowledgebase. Nucleic Acids Res 46, D649-D655, doi:10.1093/nar/gkx1132 (2018).
40. Mills, J. D. et al. Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment. Sci Rep 7, 8089, doi:10.1038/ s41598-017-06145-8 (2017).
41. Boer, K. et al. Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors. Brain Pathol 20, 704-719, doi:10.1111/ j.1750-3639.2009.00341.x (2010).
42. Boer, K. et al. Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy Res 78, 7-21, doi:10.1016/j.eplepsyres.2007.10.002 (2008).
43. Prabowo, A. S. et al. Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation. Brain Pathol 23, 45-59, doi:10.1111/j.1750-3639.2012.00616.x (2013).
44. Broekaart, D. W. M. et al. Increased matrix metalloproteinases expression in tuberous sclerosis complex: modulation by microRNA 146a and 147b in vitro. Neuropathol Appl Neurobiol, doi:10.1111/ nan.12572 (2019).
45. Franz, D. N. et al. Everolimus for subependymal giant cell astrocytoma: 5-year final analysis. Ann Neurol 78, 929-938, doi:10.1002/ana.24523 (2015).
46. Jiang, W. G. et al. Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes. Eur J Cancer 41, 1628-1636, doi:10.1016/j.ejca.2005.03.023 (2005).
47. Lesma, E. et al. The methylation of the TSC2 promoter underlies the abnormal growth of TSC2 angiomyolipoma-derived smooth muscle cells. Am J Pathol 174, 2150-2159, doi:10.2353/ ajpath.2009.080799 (2009).
48. Buccoliero, A. M. et al. Subependymal giant cell astrocytoma: a lesion with activated mTOR pathway and constant expression of glutamine synthetase. Clin Neuropathol 35, 295-301, doi:10.5414/ NP300936 (2016).
49. Lim, H. K. et al. Phosphatidic acid regulates systemic inflammatory responses by modulating the Akt-mammalian target of rapamycin-p70 S6 kinase 1 pathway. J Biol Chem 278, 45117-45127, doi:10.1074/jbc.M303789200 (2003).
50. Mi, R., Ma, J., Zhang, D., Li, L. & Zhang, H. Efficacy of combined inhibition of mTOR and ERK/MAPK pathways in treating a tuberous sclerosis complex cell model. J Genet Genomics 36, 355-361, doi:10.1016/S1673-8527(08)60124-1 (2009).
85
3